People with auto-immune conditions like MS, arthritis and lupus can benefit from low impact aerobic exercise — including walking and cycling — that increases in intensity, duration and frequency. A review of studies between 1987 and 2006 shows that 12-week programmes that involved exercising for 30 to 60 minutes, three times a week, yielded the most effective results.
More people are voluntarily getting tested for HIV, worldwide. Today, the department of health, South Africa revealed that more South Africans are voluntarily getting counselled and tested for HIV with figures rising annually.
Harvard scientists found people who ate bacon at least five times a week were 59% more likely to develop the bladder cancer than those who never did. The study appears in the American Journal of Clinical Nutrition.
Isabelle Dinoire, who had a partial face transplant a year ago, has recovered so well that she can go out without people noticing her scars, said her doctor, Professor Devauchelle, Centre Hospitalier Universitaire, Amiens, France. Isabelle says she is now able to smile.
More people die from HIV/Aids every month than in the Indian Ocean tsunami, says Professor Robert Gallo, who helped identify the HIV/AIDS virus nearly 25 years ago, said the Asian tsunami killed an estimated 230,000 people.
The longstanding advice to “sit up straight” has been turned on its head by a new study that suggests leaning back is a much better posture.
Bristol-Myers Squibb Company (NYSE: BMY) in cooperation with the National AIDS Fund today launched the third annual “Light to Unite” campaign in support of World AIDS Day. This year’s “Light to Unite” program shines a light on the devastating impact of the HIV/AIDS epidemic in underserved communities throughout the United States. Bristol-Myers Squibb and the National AIDS Fund are encouraging people across the country to visit http://www.lighttounite.org/ to show their support and to educate themselves and others on emerging HIV/AIDS issues within diverse communities across the U.S.
Perestane?, an innovative biocidal product created and developed by Solvay, has been proven to be an effective disinfectant against Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile. These so-called ?superbugs? may cause fatal diseases, and the treatment of patients with most current antibiotics is ineffective. Researchers from the University of Leeds and Leeds General Infirmary (United Kingdom) have recently demonstrated that disinfectants commonly used in hospitals fail to eradicate Clostridium difficile from the premises, and may even promote spore formation.
Solvay announces today that its vinyls joint venture in Europe, SolVin, is launching NanoVin?, an innovative nanocomposite combining polyvinyl chloride (PVC) and nanoparticles of clay. This specialty product displays exceptional properties in terms of plasticity, viscosity and flow. These distinctive rheological properties make NanoVin? a so-called ?smart material?, capable of sensing and reacting to changes in its environment (see Notes to the Editors below).
The largest-scale search for genes that underlie sporadic amyotrophic lateral sclerosis (ALS), the most common form of the disease, has crossed its first hurdle with the successful compiling of genetic information on more than 1,000 patients and controls.